What is the treatment for Pleuritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Pleuritis

The treatment of pleuritis should be tailored to the underlying cause, with combination tissue plasminogen activator (TPA) and DNase therapy recommended for complicated parapneumonic effusions or empyema where initial chest tube drainage has been inadequate. 1

Diagnostic Approach

  • Determine the underlying cause of pleuritis (viral, bacterial, autoimmune, etc.)
  • For suspected pleural infection:
    • Obtain pleural fluid samples within 24 hours for pH, glucose, LDH, protein, and culture
    • Measure pleural fluid pH with a blood gas analyzer (avoid contamination with local anesthetic or heparin)
    • Consider chest imaging (ultrasound, CT) to evaluate for loculations or effusions

Treatment Algorithm

1. Viral Pleuritis

  • Usually self-limited, resolving within 10-14 days
  • Pain management:
    • NSAIDs as first-line treatment (ibuprofen or naproxen) until pain resolves 2
    • Adequate analgesia is essential to allow deep breathing and prevent atelectasis
  • Avoid antibiotics as they provide no benefit for viral illness 2
  • Early mobilization and exercise are recommended

2. Bacterial Pleural Infection/Empyema

  • Initial management:

    • Small-bore chest tube (14F or smaller) for drainage 1
    • Start appropriate antibiotics immediately upon identification of infection
    • For community-acquired infection: amoxicillin + clavulanic acid or amoxicillin + metronidazole
    • For hospital-acquired infection: broader spectrum antibiotics (piperacillin-tazobactam, ceftazidime, or meropenem)
    • Continue antibiotics for at least 14 days
  • For complicated parapneumonic effusions or empyema with inadequate drainage:

    • Combination TPA and DNase therapy: 10 mg TPA twice daily + 5 mg DNase twice daily for 3 days 1
    • Lower doses (5 mg TPA twice daily + 5 mg DNase twice daily) may be considered for patients with higher bleeding risk
    • Single agent TPA or DNase should not be used 1
    • Streptokinase should not be used for treatment of pleural infection 1
  • Surgical intervention:

    • Consider if no improvement after 5-7 days of drainage and antibiotics
    • VATS access should be preferred over thoracotomy 1
    • Early consultation with thoracic surgeon is recommended for persistent sepsis with residual pleural collection

3. Autoimmune-Related Pleuritis

  • Treat the underlying autoimmune condition
  • NSAIDs for symptomatic relief
  • Consider corticosteroids for severe symptoms
  • Monitor for increased risk of infections, particularly tuberculosis in patients with lupus pleuritis 3

Special Considerations

Monitoring and Follow-up

  • Monitor temperature, white blood cell count, clinical symptoms, and radiographic improvement
  • Reassess if no improvement after 48-72 hours
  • Follow patients until complete recovery with chest radiograph returning to near normal

Potential Complications

  • Secondary thrombocytosis is common but benign
  • Secondary scoliosis may occur but is usually transient
  • Watch for explosive pleuritis, a medical emergency defined by rapid development of pleural effusion involving >90% of the hemithorax within 24 hours 4

Common Pitfalls to Avoid

  • Delaying drainage of complicated parapneumonic effusions
  • Using aminoglycosides as sole therapy (poor penetration into pleural space)
  • Removing chest tubes prematurely
  • Failing to adjust antibiotics based on culture results
  • Misdiagnosing the underlying cause of pleuritis

Risk Stratification

  • Use the RAPID score (Renal function, Age, Purulence, Infection source, Dietary factors) to risk stratify patients with pleural infection 2
  • Consider pulmonary embolism in patients with pleuritic chest pain (found in 5-21% of emergency department presentations) 5

By following this evidence-based approach to pleuritis management, clinicians can optimize outcomes and reduce morbidity associated with this condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Viral Pleurisy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Explosive pleuritis.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.